Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of September 5, 2012
  • Print
  • Share
  • E-mail
-
Back to Previous Page

Product Detail

Product Description Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-4699-24
Recall Number D-1672-2012
Classification Class II
Code Info 07-893-DJ, exp. 7/2013, 10-123-DJ, 10-125-DJ, exp. 10/2013
Product Distributed Qty 56,420 vials
Reason For Recall Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.

Event Detail

Event Id 62999
Product Type Drugs
Status Ongoing
Recalling Firm Hospira Inc.
City Lake Forest
State IL
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2012-08-03
Initial Firm Notification of Consignee or Public Letter
Distribution Pattern Nationwide
-
-